1. Acknowledgement to Referees

   ACKNOWLEDGEMENT TO REFEREES 06 November 2017 Pages: 879 - 880

2. The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes

   • Momir Mikov
   • Maja Đanić
   • Hani Al-Salami

   Current opinion 22 May 2017 Pages: 881 - 890

3. Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L

   • Nigel J. Waters

   Review Article 22 February 2017 Pages: 891 - 901

   

4. Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor

   • Ziad Hussein
   • Hitoshi Mizuo
   • Robert Shumaker

   Review Article 24 February 2017 Pages: 903 - 914

5. Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies

   • Ranjeet Prasad Dash
   • R. Jayachandra Babu
   • Nuggehally R. Srinivas

   Review Article 03 April 2017 Pages: 915 - 933

   

6. Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study

   • Yi-lin Wang
   • Li-feng Hsu

   Original Research Article 10 March 2017 Pages: 935 - 942

   

7. Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis

   • Mathilde Marchand
   • Patrick Brossard
   • Frank Lüdicke

   Original Research Article Open access 10 March 2017 Pages: 943 - 954

   

8. Population Pharmacokinetics to Model the Time-Varying Clearance of the PEGylated Asparaginase Oncaspar^® in Children with Acute Lymphoblastic Leukemia

   • Gudrun Würthwein
   • Claudia Lanvers-Kaminsky
   • Joachim Boos

   Original Research Article 27 March 2017 Pages: 955 - 963

   

9. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics

   • Eiko Suzuki
   • Kumiko Koyama
   • Kan Chiba

   Original Research Article 26 April 2017 Pages: 965 - 972

   

10. Physiologically Based Pharmacokinetic Modelling and Prediction of Metformin Pharmacokinetics in Renal/Hepatic-Impaired Young Adults and Elderly Populations

    • Su-jin Rhee
    • Hyewon Chung
    • Jae-Yong Chung

    Original Research Article 23 May 2017 Pages: 973 - 980

    

11. Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species

    • Ruiya Zhang
    • Yonglei Cui
    • Zhonghui Yu

    Original Research Article 23 May 2017 Pages: 981 - 992

    

12. Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis

    • Azrin N. Abd Rahman
    • Susan E. Tett
    • Christine E. Staatz

    Original Research Article 23 May 2017 Pages: 993 - 1004

    

13. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect

    • Svetlana Golocorbin-Kon
    • Jelena Calasan
    • Hani Al-Salami

    Original Research Article 25 May 2017 Pages: 1005 - 1011

    

14. Effect of Long-term In Vitro Lithium Exposure on mRNA Levels of Claudin-3, CYP1A1, ABCG2 and GSTM3 Genes in the hCMEC/D3 Human Brain Endothelial Cell Line

    • Ramzi Shawahna
    • Kayathiri Ganeshamoorthy
    • Xavier Declèves

    Short Communication 03 April 2017 Pages: 1013 - 1017

15. Comments on: “Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension”

    • Nuggehally R. Srinivas

    Letter to the Editor 11 September 2017 Pages: 1019 - 1021